4D Molecular Therapeutics, Inc.

NASDAQ:FDMT

Biotechnology

Healthcare
$10.46 +1.70%

+$0.16 today

Market cap
$577.85M
Beta
2.76
P/E (TTM)
-4.0
EPS (TTM)
-$2.36
52W Low $3.68High $12.34

Volume 0.68M

Average 0.77M

Balance Sheet

Inspect the capital base behind the business.

Assets

$566.71M

FY 2025 · Annual

+1.1% YoY

Liabilities

$61.05M

FY 2025 · Annual

+22.6% YoY

Equity

$505.66M

FY 2025 · Annual

-1.0% YoY

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents153M52.35M249.11M149.34M60.24M
Short-term Investments94.78M161.2M39.12M275.54M342.41M
Net Receivables47K700K000
Inventory00000
Other Current Assets8.46M6.26M8.36M10.06M10.48M
Total Current Assets256.28M220.51M296.59M434.93M413.13M
Property, Plant & Equipment (Net)28.95M35.35M31.67M40.61M33.01M
Goodwill00000
Intangible Assets00000
Long-term Investments67.65M4.91M10.95M80.58M111.38M
Tax Assets00000
Other Non-current Assets602K1.08M684K4.26M9.19M
Total Non-current Assets97.21M41.34M43.3M125.45M153.58M
Total Assets353.49M261.85M339.89M560.38M566.71M
Account Payables4.76M3.32M3.52M4.39M11.16M
Short-term Debt02.66M000
Tax Payables00000
Deferred Revenue2.6M884K273K257K360K
Other Current Liabilities03.18M3.87M00
Total Current Liabilities16.34M15.73M18.95M29.15M43.99M
Long-term Debt00000
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)2.49M1.08M972K1.06M745K
Other Non-current Liabilities334K233K617K603K496K
Total Non-current Liabilities18.04M14.78M13.11M20.63M17.06M
Total Liabilities34.38M30.51M32.06M49.78M61.05M
Common Stock3K3K4K5K6K
Retained Earnings(207M)(314.49M)(415.33M)(576.2M)(716.3M)
Accumulated OCI(423K)(1.2M)16K229K727K
Other Stockholders Equity00000
Minority Interest00000
Total Equity319.11M231.34M307.83M510.61M505.66M
Total Debt16.45M16.12M14.67M24.61M21.41M
Net Debt(136.55M)(36.23M)(234.44M)(124.73M)(38.83M)

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$72.5M
Short-term Investments$318.4M
Other Current$14.5M
Total Current Assets$405.4M
PP&E (Net)$30.9M
Long-term Investments$66.7M
Other Non-current$9.9M
Total Non-current Assets$107.5M
Total Assets$512.9M

Analysis

Selected assets total $512.9M for Latest. The largest visible component is Short-term Investments at $318.4M, about 62.1% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
8-KCurrent reportNov 12, 2026
10-QQuarterly reportNov 12, 2026
SC 13GSC 13G filingNov 10, 2026
4Statement of changes in beneficial ownershipOct 20, 2026
4Statement of changes in beneficial ownershipOct 7, 2026

How much cash does FDMT have?

4D Molecular Therapeutics, Inc. (FDMT) reported $60.24M in cash and equivalents in fiscal 2025.

How much debt does FDMT carry?

4D Molecular Therapeutics, Inc. (FDMT) reported $21.41M of total debt, with net debt of -$38.83M.